Published in Medicine and Law Weekly, January 14th, 2005
Over the prior year Schott had conducted a market test, distributing Accelr8's microarray slides under Schott's Nexterion brand. The license marks the end of a successful market test during which Schott Nexterion developed strong product interest, particularly in emerging applications for protein microarraying.
The supply agreement is the second in the past year. Over...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.